Table 2.
Associations between predictors and new-onset CKD during a maximum period of 18 years follow-up
| Predictors | Duration ± SD (months) |
Cases | Incidence (%) |
Hazard ratio | 95% CI |
|---|---|---|---|---|---|
| Uric acid (mg/dL) | |||||
| > 7.0 | 76.3 ± 63.3 | 32 | 19.3 | 3.99 | 2.59, 6.15 |
| ≤ 7.0 | 98.0 ± 66.8 | 68 | 6.1 | 1.00 | |
| HDL-C (mg/dL) | |||||
| < 40 | 89.3 ± 61.5 | 18 | 11.8 | 1.69 | 1.00, 2.86 |
| ≥ 40 | 96.0 ± 67.4 | 82 | 7.2 | 1.00 | |
| Blood pressure (mmHg) | |||||
| SBP ≥ 140 or DBP ≥ 90 | 83.5 ± 62.8 | 33 | 12.9 | 2.00 | 1.29, 3.11 |
| SBP < 140 and DBP < 90 | 98.1 ± 67.4 | 67 | 6.5 | 1.00 | |
| Fasting blood sugar (mg/dL) | |||||
| ≥ 126 | 95.1 ± 66.0 | 3 | 5.9 | 0.56 | 0.17, 1.77 |
| < 126 | 95.2 ± 66.8 | 97 | 7.9 | 1.00 | |
| Body mass index (kg/m2) | |||||
| ≥ 25.0 | 93.2 ± 66.4 | 34 | 12.5 | 1.35 | 0.87, 2.10 |
| < 25.0 | 95.7 ± 66.8 | 66 | 6.5 | 1.00 |
CKD, chronic kidney disease; SD, standard deviation; CI, confidence interval;
HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure.